March 2017

FDA Testing Shows Belladonna Found in Teething Products

The U.S. Food & Drug Administration has announced that testing results show some homeopathic teething tablets contain high levels of belladonna, several with amounts exceeding what is listed on the product label. These products have been linked to reports of seizures, difficulty breathing, muscle weakness, excessive sleepiness, constipation, difficulty urinating, agitation, and death in infants.

The FDA first notified consumers of the potential risks associated with these tablets back in 2010, and again in September 2016. These new findings have prompted the FDA to contact Standard Homeopathic Company, the manufacturer of Hyland's homeopathic teething products, to request a recall. Consumers are advised to stop giving homeopathic teething products to their infants.


  1. Abbasi J. Amid Reports of Infant Deaths, FTC Cracks Down on Homeopathy While FDA Investigates. JAMA. 2017;317(8):793-795.
  2. U.S. Food & Drug Administration. FDA confirms elevated levels of belladonna in certain homeopathic teething products.

The information in this brief report is intended for informational purposes only, and is meant to help users better understand health concerns. This information should not be interpreted as specific medical advice. Users should consult with a qualified healthcare provider for specific questions regarding therapies, diagnosis and/or health conditions, prior to making therapeutic decisions. Copyright © 2024 NatMed. Commercial distribution or reproduction prohibited. NatMed is the leading provider of high-quality, evidence-based, clinically-relevant information on natural medicine, dietary supplements, herbs, vitamins, minerals, functional foods, diets, complementary practices, CAM modalities, exercises and medical conditions. Monograph sections include interactions with herbs, drugs, foods and labs, contraindications, depletions, dosing, toxicology, adverse effects, pregnancy and lactation data, synonyms, safety and effectiveness.